EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selection and Characterization of Cell Line–Virus Pairs for Sensitive Viral Detection Assays in Biopharmaceutical Testing

Agnieszka Staniszewska iD, Agnieszka Piastowska-Ciesielska iD

Methods and Protocols · 08.07.2026 · 9 (4) · 107

DOI: 10.3390/mps9040107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods and Protocols, online erschienen am 08.07.2026. Verfasst von Agnieszka Staniszewska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, 90-752 Lodz, Poland. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ensuring viral safety is a critical aspect of biopharmaceutical production, requiring sensitive and reliable methods for detecting adventitious agents. In this study, we systematically evaluated the performance of selected cell line–virus combinations to identify optimal models for in vitro viral detection assays. Three cell lines (Vero, MRC-5 and BHK-21 [C-13]) and representative model viruses (Reovirus type 3, Adenovirus type 5, Human parainfluenza virus type 3, and Herpes simplex virus) were analyzed in terms of cytopathic effect (CPE) kinetics, morphology, and detection sensitivity. All tested systems demonstrated high analytical sensitivity, with limits of quantification (LOQ) reaching 0.01 TCID50/mL for selected viruses. However, substantial differences were observed in infection dynamics and CPE morphology depending on the cell line–virus combination. BHK-21 [C-13] cells exhibited the most rapid and pronounced CPE for Reovirus type 3, enabling early and unambiguous detection. Vero cells provided robust and reproducible detection of Adenovirus type 5, characterized by well-defined cytopathic progression. MRC-5 cells showed controlled and consistent infection kinetics for both Human parainfluenza virus type 3 and Herpes simplex virus, allowing improved temporal resolution and interpretability. These findings demonstrate that assay performance depends not only on sensitivity but also on the kinetics and morphology of infection. Based on combined evaluation criteria, the following optimal cell line–virus pairs were identified: BHK-21 [C-13]/Reovirus type 3, Vero/Adenovirus type 5, and MRC-5/Human parainfluenza virus type 3 and Herpes simplex virus. The proposed approach supports rational selection of detection models and provides a preliminary descriptive framework for the development of routine visual screening assays in biopharmaceutical quality control.

Schlagwörter

Stichwörter der Autor:innen

Adenovirus type 5BHK-21MRC-5Reovirus type 3TCID50Vero cellsadventitious agentsbiopharmaceuticalscell line–virus pairingcytopathic effect (CPE)herpes simplex virushuman parainfluenza virus type 3in vitro assaylimit of quantification (LOQ)quality control

Autor:innen und Institutionen

  • Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, 90-752 Lodz, Poland.

ORCID-Profile: Agnieszka Staniszewska, Agnieszka Piastowska-Ciesielska

Förderung

  • Ministry of Science and Higher Education of Poland

Zitieren

APA

Staniszewska, A., & Piastowska-Ciesielska, A. (2026). Selection and Characterization of Cell Line–Virus Pairs for Sensitive Viral Detection Assays in Biopharmaceutical Testing. Methods and Protocols, 9(4), 107. https://doi.org/10.3390/mps9040107

Vancouver

Staniszewska A, Piastowska-Ciesielska A. Selection and Characterization of Cell Line–Virus Pairs for Sensitive Viral Detection Assays in Biopharmaceutical Testing. Methods and Protocols. 2026;9(4):107. doi:10.3390/mps9040107

BibTeX
@article{Staniszewska2026,
  author = {Staniszewska, Agnieszka and Piastowska-Ciesielska, Agnieszka},
  title = {Selection and Characterization of Cell Line–Virus Pairs for Sensitive Viral Detection Assays in Biopharmaceutical Testing},
  journal = {Methods and Protocols},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {107},
  doi = {10.3390/mps9040107}
}
Kostenlos starten →